InAdvance: Surveillance, Prevention, and Interception in a Population at Risk for Cancer

Clinical trial NCT05463796 · RECRUITING

Trial details

NCT number: NCT05463796
Sponsor: Dana-Farber Cancer Institute
Status: RECRUITING
Study type: OBSERVATIONAL

Cancer Risk Cancer Predisposition Syndrome Hereditary Cancer Prediction Childhood Cancer Survivors Adult Cancer Survivors IARC Carcinogens Smoking History Lung Cancer Ductal/Lobular Carcinoma Barrett Esophagus Pancreatic Precursor Lesions Colonic Dysplasia/Adenomata

Start date: 2023-04-25
Primary completion: 2030-03-25
Enrollment: 5000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.